Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
While cough, cold and allergy (hay fever) remedies is expected to register an increase in current value sales, constant value sales are expected to fall slightly in 2022. Rising inflation as a result of the energy crisis stemming from the war in Ukraine is pushing up retail prices and dampening volume sales somewhat. Pharyngeal preparations are expected to register the highest current value growth and also an increase in volume sales.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Denmark report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Euromonitor International
- September 2022
- List Of Contents And Tables
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN DENMARK
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Slight fall in constant value sales in 2022
- GSK Consumer Healthcare maintains its leading position, as generics also continue to gain groundÂ
- CBD as an ingredient continues to grow in popularity
- PROSPECTS AND OPPORTUNITIES
- Muted constant value growth over forecast period
- Vaccines for allergies could dampen value growth of allergy remedies over long term
- Climate changes leads to increased allergies
- CATEGORY DATA
- Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
- Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
- Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
- Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
- Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN DENMARK
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources